In summary, our data identified a posttranscriptional TRIM25-hnRNPH1-caspase-7 axis as a novel pathway potentially contributing to the apoptosis resistance of CRC cells towards pharmacological stressors and highlighted TRIM25 inhibitory strategies as a novel strategy for CRC management in clinical practice. Here, CASP7 is linked to colorectal carcinoma.